Lili Wang

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Skeletal Muscle

Top Venues

Nature biotechnology

Science advances

University of Pennsylvania

Rutgers University New Brunswick (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pennsylvania Jul 5o 1999

United States

Research Associate Professor :: Gene Therapy Program, Department of Medicine

Education History

Rutgers University New Brunswick

United States

PHD :: Microbiology & Molecular Genetics

Publications

Jenny A Greig, Kelly M Martins, Camilo Breton, R Jason Lamontagne, Yanqing Zhu, Zhenning He, John White, Jing-Xu Zhu, Jessica A Chichester, Qi Zheng, Zhe Zhang, Peter Bell, Lili Wang, James M Wilson
Integrated vector genomes may contribute to long-term expression in primate liver after AAV administration. Nature biotechnology (2023)
Alexander Kistner, Jessica A Chichester, Lili Wang, Roberto Calcedo, Jenny A Greig, Leah N Cardwell, Margaret C Wright, Julien Couthouis, Sunjay Sethi, Brian E McIntosh, Kathleen McKeever, Samuel Wadsworth, James M Wilson, Emil Kakkis, Barbara A Sullivan
Prednisolone and rapamycin reduce the plasma cell gene signature and may improve AAV gene therapy in cynomolgus macaques. Gene therapy (2023)
Lili Wang, Yang Yang, Camilo Breton, Peter Bell, Mingyao Li, Jia Zhang, Yan Che, Alexei Saveliev, Zhenning He, John White, Caitlin Latshaw, Chenyu Xu, Deirdre McMenamin, Hongwei Yu, Hiroki Morizono, Mark L Batshaw, James M Wilson
A mutation-independent CRISPR-Cas9-mediated gene targeting approach to treat a murine model of ornithine transcarbamylase deficiency. Science advances 6 (7) (2020)
Lili Wang, Yang Yang, Camilo Ayala Breton, John White, Jia Zhang, Yan Che, Alexei Saveliev, Deirdre McMenamin, Zhenning He, Caitlin Latshaw, Mingyao Li, James M Wilson
CRISPR/Cas9-mediated in vivo gene targeting corrects hemostasis in newborn and adult factor IX-knockout mice. Blood 133 (26) (2019)